- Home
- APLT vs SSRM Comparison
APLT vs SSRM Comparison
Compare APLT & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | SSRM |
|---|---|---|
| Founded | 2016 | 1946 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 4.5B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | APLT | SSRM |
|---|---|---|
| Price | $0.12 | $22.17 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $1.25 | ★ $21.89 |
| AVG Volume (30 Days) | ★ 27.2M | 2.2M |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | $1,000,000.00 | ★ $1,431,099,000.00 |
| Revenue This Year | $124.18 | $58.80 |
| Revenue Next Year | $66.67 | $45.35 |
| P/E Ratio | ★ N/A | $21.16 |
| Revenue Growth | N/A | ★ 30.30 |
| 52 Week Low | $0.11 | $6.79 |
| 52 Week High | $1.50 | $25.98 |
Technical Indicators
Market Signals| Indicator | APLT | SSRM |
|---|---|---|
| Relative Strength Index (RSI) | 25.40 | 54.11 |
| Support Level | $0.21 | $20.81 |
| Resistance Level | $0.26 | $21.98 |
| Average True Range (ATR) | 0.02 | 0.94 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 5.13 | 60.37 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.